HighTower Advisors
GLSI icon

HighTower Advisors’s Greenwich LifeSciences GLSI Stock Holding History

HighTower Advisors’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,967
Closed -$154K – 3927
2025
Q2 		$154K Buy
16,967
+1,560
+10% +$14.8K ﹤0.01% 3378
2025
Q1 		$147K Buy
+15,407
New +$187K ﹤0.01% 3274

Other funds holding GLSI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $25.2B AUM 30.31% 1-Year Est. Return

HighTower Advisors's GLSI Position: Q3 2025 in Review

HighTower Advisors sold out of Greenwich LifeSciences (GLSI) in Q3 2025, closing a stake of 16,967 shares — an estimated $154K sold.

HighTower Advisors first reported a position in GLSI in Q1 2025 and held it in 2 quarters. The position peaked at $154K in Q2 2025. 51 funds tracked by Wall St. Rank hold GLSI as of Q3 2025.

  • HighTower Advisors reported no remaining Greenwich LifeSciences position as of Q3 2025 after selling out during the quarter.
  • HighTower Advisors sold 16,967 Greenwich LifeSciences shares in Q3 2025, an estimated $154K.
  • HighTower Advisors first reported a position in Greenwich LifeSciences in Q1 2025 and held it in 2 quarters.
  • HighTower Advisors's Greenwich LifeSciences position peaked at $154K in Q2 2025.
  • 51 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q3 2025.

Based on HighTower Advisors's 13F filing for Q3 2025, filed 7 Nov 2025.